These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28398367)

  • 1. [Implantable cardioverter-defibrillator deactivation at the end of life: ethical, clinical and communication issues].
    Romanò M; Piga MA; Bertona R; Negro R; Ruggeri C; Zorzoli F; Villani R
    G Ital Cardiol (Rome); 2017 Feb; 18(2):139-149. PubMed ID: 28398367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Implantable cardiac device deactivation at the end of life].
    Romanò M; Gorni G
    G Ital Cardiol (Rome); 2020 Apr; 21(4):286-295. PubMed ID: 32202561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICD recipients' understanding of ethical issues, ICD function, and practical consequences of withdrawing the ICD in the end-of-life.
    Strömberg A; Fluur C; Miller J; Chung ML; Moser DK; Thylén I
    Pacing Clin Electrophysiol; 2014 Jul; 37(7):834-42. PubMed ID: 24483943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer.
    England R; England T; Coggon J
    J Med Ethics; 2007 Sep; 33(9):538-40. PubMed ID: 17761824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations.
    Carlsson J; Paul NW; Dann M; Neuzner J; Pfeiffer D
    Dtsch Arztebl Int; 2012 Aug; 109(33-34):535-41. PubMed ID: 23152737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
    Russo JE
    Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ethics of unilateral implantable cardioverter defibrillators and cardiac resynchronization therapy with defibrillator deactivation: patient perspectives.
    Daeschler M; Verdino RJ; Kirkpatrick JN
    Europace; 2017 Aug; 19(8):1343-1348. PubMed ID: 27915265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defibrillator patients should not be denied a peaceful death.
    Westerdahl AK; Sutton R; Frykman V
    Int J Cardiol; 2015 Mar; 182():440-6. PubMed ID: 25597981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.
    Kramer DB; Kesselheim AS; Salberg L; Brock DW; Maisel WH
    Am J Cardiol; 2011 Apr; 107(7):1071-1075.e5. PubMed ID: 21296323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey.
    Kelley AS; Reid MC; Miller DH; Fins JJ; Lachs MS
    Am Heart J; 2009 Apr; 157(4):702-8.e1. PubMed ID: 19332199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical and legal perspective of implantable cardioverter defibrillator deactivation or implantable cardioverter defibrillator generator replacement in the elderly.
    Wright GA; Klein GJ; Gula LJ
    Curr Opin Cardiol; 2013 Jan; 28(1):43-9. PubMed ID: 23128499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations in Patients With Cardiac Implantable Electronic Devices at End of Life.
    Gura MT
    AACN Adv Crit Care; 2015; 26(4):356-63. PubMed ID: 26484996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D; Stros P; Curila K; Kebza V; Osmancik P
    Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deactivation of implantable cardioverter-defibrillators at end of life.
    Pettit SJ; Jackson CE; Gardner RS
    Future Cardiol; 2013 Nov; 9(6):885-96. PubMed ID: 24180544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lost in translation: examining patient and physician perceptions of implantable cardioverter-defibrillator deactivation discussions.
    Mitar M; Alba AC; MacIver J; Ross H
    Circ Heart Fail; 2012 Sep; 5(5):660-6. PubMed ID: 22991406
    [No Abstract]   [Full Text] [Related]  

  • 16. Planning for Deactivation of Implantable Cardioverter Defibrillators at the End of Life in Patients With Heart Failure.
    Brady DR
    Crit Care Nurse; 2016 Dec; 36(6):24-31. PubMed ID: 27908943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
    Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; van Bruchem-Visser RL; Theuns DA; Bhagwandien RE; Van der Heide A; Rietjens JA
    Heart; 2020 Feb; 106(3):190-195. PubMed ID: 31537636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
    McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
    Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' perception of implantable cardioverter defibrillator deactivation at the end of life.
    Hill L; McIlfatrick S; Taylor B; Dixon L; Harbinson M; Fitzsimons D
    Palliat Med; 2015 Apr; 29(4):310-23. PubMed ID: 25239128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deactivation of pacemakers and implantable cardioverter-defibrillators.
    Kramer DB; Mitchell SL; Brock DW
    Prog Cardiovasc Dis; 2012; 55(3):290-9. PubMed ID: 23217433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.